Effects of a 12-Week Web-Based Weight Loss Program for Adults With Overweight and Obesity on Covidage and Lifestyle-Related Cardiometabolic Risk Factors
A Randomized Controlled Trial
Bibliographic Data
| ID | 22071233 |
|---|---|
| Authors | Judith Brame (0000-0002-7283-5600, University of Freiburg, corresponding author), Christoph Centner (0000-0001-6839-4438, University of Freiburg), Niklas Berg (University of Freiburg), Matt Bartlam (Everist Health (United States)), Albert Gollhofer (0009-0006-8172-4693, University of Freiburg), Daniel König (0000-0002-4104-4013, University of Vienna) |
| Year | 2022 |
| Volume | 10 |
| Pages | 868255-868255 |
| Publication date | 2022-05-20 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Public Health (JOURNAL) |
| Journal identifiers | ISSN: 2296-2565 • E-ISSN: 2296-2565 |
| Publisher | Frontiers Media SA (PUBLISHER • CH) |
| DOI | 10.3389/fpubh.2022.868255 |
| PMID | 35669738 |
| OpenAlex | W4280488234 |
| Language | EN |
| References cited | 41 |
The coronavirus disease 2019 (COVID-19) pandemic has induced unhealthy lifestyles, particularly an increase in overweight and obesity, which have been shown to be associated with an increased risk of unfavorable COVID-19 outcomes. Web-based health programs could be a helpful measure, especially in times of severe restrictions. Therefore, the present study aimed to investigate the effects of regular attendance in a 12-week web-based weight loss program on COVIDAge, a new construct for risk assessment of COVID-19, and lifestyle-related cardiometabolic risk factors. N = 92 subjects with overweight and obesity (50.0 ± 10.8 years, 76.1% females, 30.5 ± 2.1 kg/m 2 ) of this randomized controlled trial, which were assigned to an interactive (ONLINE: intervention group) or non-interactive (CON: control group) web-based weight loss program, were included in the data analysis. COVIDAge and cardiometabolic risk factors, including anthropometric outcomes, blood pressure, flow-mediated dilatation, and blood parameters, were assessed before and after the 12-week intervention phase. There was a significant group difference in the change of COVIDAge (ONLINE: −4.2%, CON: −1.3%, p = 0.037). The ONLINE group also showed significantly greater reductions in anthropometric outcomes and systolic blood pressure than the CON group ( p < 0.05). To the authors' knowledge, this was the first study investigating the effects of regular attendance in a web-based health program on lifestyle-related risk factors for COVID-19. The results demonstrated that adults with overweight and obesity can improve their COVIDAge and specific cardiometabolic risk factors by using this interactive web-based weight loss program regularly. However, this needs to be confirmed by future studies. This study is registered at the German Clinical Trials Register (DRKS00020249, https://www.drks.de )
Anthropometry · Attendance · Blood pressure · Obesity · Overweight · Physical therapy · Randomized controlled trial · Weight loss · COVID-19 and Mental Health · COVID-19 Clinical Research Studies · Long-Term Effects of COVID-19 · Medicine · Gerontology · Internal Medicine
Estimating the effects of non-pharmaceutical interventions on Covid-19 in Europe
Effects of Covid-19 Home Confinement on Eating Behaviour and Physical Activity
Individuals with obesity and Covid‐19
Inferring change points in the spread of Covid-19 reveals the effectiveness of interventions
Eating habits and lifestyle changes during Covid-19 lockdown
The global epidemiology of hypertension
G*Power 3
Mental Health During Covid-19 Lockdown in the United Kingdom
Health Effects of a 12-Week Web-Based Lifestyle Intervention for Physically Inactive and Overweight or Obese Adults
A brief-review of the risk factors for covid-19 severity
| Citation velocity | historical |
|---|---|
| Highly cited | No |